|
H2AFV expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.206100E-04 |
| Normal-vs-Stage3 |
4.88498130835069E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.522080E-02 |
| Stage1-vs-Stage3 |
1.473160E-01 |
| Stage1-vs-Stage4 |
1.401820E-04 |
| Stage2-vs-Stage3 |
1.655030E-03 |
| Stage2-vs-Stage4 |
2.10339999999754E-05 |
| Stage3-vs-Stage4 |
4.968000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.17110000036536E-07 |
| Normal-vs-Asian |
1.73139280690293E-12 |
| Caucasian-vs-AfricanAmerican |
5.373600E-01 |
| Caucasian-vs-Asian |
4.224000E-01 |
| AfricanAmerican-vs-Asian |
2.521400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93098878501041E-14 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.987200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
2.04847250273588E-12 |
| Normal-vs-Age(81-100Yrs) |
8.818000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.375000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.715400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.015000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.299200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.784000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.790000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.578390E-03 |
| Classical-VS-Follicular |
2.304800E-03 |
| Classical-VS-Other |
4.999600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.11469999999991E-06 |
| Tall-VS-Other |
6.570000E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
1.394640E-01 |
| Follicular-VS-Normal |
1.34949999952561E-07 |
| Other-VS-Normal |
6.37339999999265E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8043344596208E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.29240000000553E-05 |
|
|
